Ambroxol for the prevention of acute upper respiratory disease

Clinical and Experimental Medicine

Volumn 6, Issue 2, 2006, Pages 79-83

  Nobata, K ^a   Fujimura, M ^a   Ishiura, Y ^a   Myou, S ^a   Nakao, S ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Acute upper respiratory disease; Ambroxol; Common cold; Influenza; Prevention

Indexed keywords

AMBROXOL; CARBOCISTEINE; INFLUENZA VACCINE; REBAMIPIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INFLUENZA; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; STATISTICAL SIGNIFICANCE; UPPER RESPIRATORY TRACT;

AGED; AGED, 80 AND OVER; ALANINE; AMBROXOL; CARBOCYSTEINE; FEMALE; HUMANS; MALE; QUINOLONES; RESPIRATORY TRACT INFECTIONS;

ORTHOMYXOVIRIDAE;

EID: 33745713105     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-006-0099-2     Document Type: Article

References (16)

1. Olivieri D, Zavattini G, Tomasini G, Daniotti S, Bonsignore G, Ferrara G, Carnimeo N, Chianese R, Catena E, Marcatili S (1987) Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Respiration 51:42-51
2. _ (1989) Prevention of chronic bronchitis exacerbations with ambroxol (mucosolvan retard). An open, long-term, multicenter study in 5635 patients. Respiration 55:84-96
3. Post M, Batenburg JJ, Schuurmans EA, Oldenborg V, van der Molen AJ, van Golde LM (1983) The perfused rat lung as a model for studies on the formation of surfactant and the effect of ambroxol on this process. Lung 161:349-359
4. Heath MF, Jacobson W (1985) The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant. Lung 163:337-344
5. Urashima H, Okamoto T, Takeji Y, Shinohara H, Fujisawa S (2004) Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model. Cornea 6:613-619
6. Tenner AL, Robinson SL, Borchelt J, Wright JR (1989) Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J Biol Chem 263:13923-13928
7. Wright JR, Wager RE, Hawgood S, Dobbs L, Clements JA (1987) Surfactant apoprotein Mr=26,000-36,000 enhances uptake of liposomes by type II cells. J Biol Chem 262:2888-2894
8. Kido H, Sakai K, Kishino Y, Tashiro M (1993) Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus. FEBS Lett 322:115-119
9. Germouty J, Jirou-Najou JL (1987) Clinical efficacy of ambroxol in the treatment of bronchial stasis. Respiration 51:37-41
10. Heath MF, Jacobson W (1985) The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant. Lung 163:337-344
11. Tashiro M, Beppu Y, Sakai K, Kido H (1996) Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs. Arch Virol 141:1571-1577
12. Gillissen A, Scharling B, Jaworska M, Bartling A, Rasche K, Schultze-Werninghaus G (1997) Oxidant scavenger function of ambroxol in vitro: a comparison with N-acetylcysteine AC. Res Exp Med 196:389-398
13. Pfeifer S, Zissel G, Kienast K, Muller-Quernheim J (1997) Reduction of cytokine release from blood and bronchoalveolar mononuclear cells by ambroxol. Eur J Med Res 2:129-132
14. Gibbs BF, Schmutzler W, Vollrath IB, Brosthardt P, Braam U, Wolff HH, Zwadlo-Klarwasser G (1999) Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells. Inflamm Res 48:86-93
15. Yang B, Yao DF, Ohuchi M, Ide M, Yano M, Okumura Y, Kido H (2002) Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels. Eur Respir J 19:952-958
16. Gillissen A, Bartling A, Schoen S, Schultze-Werninghaus G (1997) Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung 175:235-242